TC Biopharm (Holdings) plc intends to begin proof-of-concept preclinical studies for its lead therapeutic TCB-008, to treat H5N1, or bird flu. TCB-008 is an allogeneic, unmodified cell therapy ...

Just days before Quinyana Price rushed to the HCMC emergency room in Minneapolis, Betsy Murray went to Memorial Blood Center ...